Invention Grant
- Patent Title: Compositions for treating neurodegenerative diseases
-
Application No.: US16613697Application Date: 2018-05-15
-
Publication No.: US11214540B2Publication Date: 2022-01-04
- Inventor: Gilbert M. Rishton , Gary C. Look , Susan M. Catalano
- Applicant: COGNITION THERAPEUTICS, INC.
- Applicant Address: US PA Pittsburgh
- Assignee: COGNITION THERAPEUTICS, INC.
- Current Assignee: COGNITION THERAPEUTICS, INC.
- Current Assignee Address: US PA Pittsburgh
- Agency: Troutman Pepper Hamilton Sanders LLP
- International Application: PCT/US2018/032726 WO 20180515
- International Announcement: WO2018/213281 WO 20181122
- Main IPC: C07D491/107
- IPC: C07D491/107 ; C07D205/04 ; C07D207/08 ; C07D207/16 ; C07D211/22 ; C07D211/46 ; C07D211/48 ; C07D241/04 ; C07D241/08 ; C07D265/30 ; C07D401/04 ; C07D403/06 ; C07D403/14 ; C07D405/04 ; C07D405/12 ; C07D413/14
Abstract:
The present disclosure relates to novel compounds, and pharmaceutical compositions thereof, useful for treating for treating neurodegenerative diseases, including Alzheimer's disease and cognitive decline. Methods for inhibiting synapse number decline or membrane trafficking abnormalities associated with exposure of a neuronal cell to Abeta species are also disclosed. Representative members of these compounds include:
Public/Granted literature
- US20200299234A1 COMPOSITIONS FOR TREATING NEURODEGENERATIVE DISEASES Public/Granted day:2020-09-24
Information query
